These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21479803)

  • 1. Hepatocellular carcinoma: MR staging and therapeutic decisions.
    Bargellini I
    Abdom Imaging; 2012 Apr; 37(2):231-8. PubMed ID: 21479803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of HCC.
    de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
    J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intermediate hepatocellular carcinoma stage: Should treatment be expanded?
    Piscaglia F; Bolondi L
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S258-63. PubMed ID: 20547312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
    Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal treatment of hepatocellular carcinoma.
    Graf D; Vallböhmer D; Knoefel WT; Kröpil P; Antoch G; Sagir A; Häussinger D
    Eur J Intern Med; 2014 Jun; 25(5):430-7. PubMed ID: 24666568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential prognostic impact of renal insufficiency on patients with hepatocellular carcinoma: a propensity score analysis and staging strategy.
    Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Chiou YY; Lee RC; Lee FY; Huo TI; Lee SD
    J Gastroenterol Hepatol; 2012 Apr; 27(4):690-9. PubMed ID: 22436058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment strategy for hepatocellular carcinoma.
    Ng KK; Poon RT
    Saudi Med J; 2007 Sep; 28(9):1330-8. PubMed ID: 17768455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization for hepatocellular carcinoma: significance of extrahepatic collateral supply.
    Paul SB; Gamanagatti SR; Mukund A; Abbas SZ; Acharya SK
    Indian J Cancer; 2011; 48(3):339-44. PubMed ID: 21921335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B).
    Yamakado K; Kudo M
    Oncology; 2014; 87 Suppl 1():78-81. PubMed ID: 25427737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.
    Llovet JM; Fuster J; Bruix J;
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S115-20. PubMed ID: 14762851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsurgical treatment of hepatocellular carcinoma.
    Llovet JM; Sala M; Bruix J
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages.
    D'Avola D; Iñarrairaegui M; Pardo F; Rotellar F; Marti P; Bilbao JI; Martinez-Cuesta A; Benito A; Alegre F; Mauleón E; Herrero JI; Quiroga J; Prieto J; Sangro B
    Ann Surg Oncol; 2011 Jul; 18(7):1964-71. PubMed ID: 21267791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY
    Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern diagnosis and management of hepatocellular carcinoma.
    Marrero JA; Welling T
    Clin Liver Dis; 2009 May; 13(2):233-47. PubMed ID: 19442916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatocellular carcinoma.
    Blum HE
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The size of the problem: clinical algorithms.
    Forner A; Bruix J
    Dig Dis; 2013; 31(1):95-103. PubMed ID: 23797130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the treatment of hepatocellular carcinoma.
    Padhya KT; Marrero JA; Singal AG
    Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging of hepatocellular carcinoma.
    Yan P; Yan LN
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):491-5. PubMed ID: 14627506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and multimodal therapy for hepatocellular carcinoma].
    Kolligs FT; Hoffmann RT; op den Winkel M; Bruns CJ; Herrmann K; Jakobs TF; Lamerz R; Trumm C; Zech CJ; Wilkowski R; Graeb C
    Z Gastroenterol; 2010 Feb; 48(2):274-88. PubMed ID: 20119895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.